|
Search
Collections
Benchmarks
Upload document
Organization
Casey Cosgrove
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
Phase II Trial of Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma
Status: Recruiting
, Estimated PCD: 2024-12-31
